These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR, El-Zammar O. Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [Abstract] [Full Text] [Related]
3. Immunohistochemical evaluation of necrotic malignant melanomas. Nonaka D, Laser J, Tucker R, Melamed J. Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838 [Abstract] [Full Text] [Related]
4. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi. Mirecka J, Korabiowska M, Schauer A. Pol J Pathol; 1995 May; 46(3):167-72. PubMed ID: 7496736 [Abstract] [Full Text] [Related]
5. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Böni R, Burg G, Doguoglu A, Ilg EC, Schäfer BW, Müller B, Heizmann CW. Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623 [Abstract] [Full Text] [Related]
9. The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Kazakov DV, Kutzner H, Rütten A, Michal M, Requena L, Burg G, Dummer R, Kempf W. Am J Dermatopathol; 2004 Apr; 26(2):102-7. PubMed ID: 15024190 [Abstract] [Full Text] [Related]
11. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma. Gleason BC, Nascimento AF. Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958 [Abstract] [Full Text] [Related]
13. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas. Yu CH, Chen HH, Liu CM, Jeng YM, Wang JT, Wang YP, Liu BY, Sun A, Chiang CP. J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892 [Abstract] [Full Text] [Related]